190 related articles for article (PubMed ID: 30503695)
41. Seroprevalence of HCV and HIV infection among clients of the nation's longest-standing statewide syringe exchange program: A cross-sectional study of Community Health Outreach Work to Prevent AIDS (CHOW).
Salek TP; Katz AR; Lenze SM; Lusk HM; Li D; Des Jarlais DC
Int J Drug Policy; 2017 Oct; 48():34-43. PubMed ID: 28779632
[TBL] [Abstract][Full Text] [Related]
42. Hepatitis C Virus in people with experience of injection drug use following their displacement to Southern Ukraine before 2020.
Yakovleva A; Kovalenko G; Redlinger M; Smyrnov P; Tymets O; Korobchuk A; Kotlyk L; Kolodiazieva A; Podolina A; Cherniavska S; Antonenko P; Strathdee SA; Friedman SR; Goodfellow I; Wertheim JO; Bortz E; Meredith L; Vasylyeva TI
BMC Infect Dis; 2023 Jul; 23(1):446. PubMed ID: 37400776
[TBL] [Abstract][Full Text] [Related]
43. Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.
Leprêtre A; Ba I; Lacombe K; Maynart M; Toufik A; Ndiaye O; Kane CT; Gozlan J; Tine J; Ndoye I; Raguin G; Girard PM
J Int AIDS Soc; 2015; 18(1):19888. PubMed ID: 26004637
[TBL] [Abstract][Full Text] [Related]
44. Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.
Jordan AE; Des Jarlais DC; Arasteh K; McKnight C; Nash D; Perlman DC
Drug Alcohol Depend; 2015 Jul; 152():194-200. PubMed ID: 25891230
[TBL] [Abstract][Full Text] [Related]
45. Integrated respondent-driven sampling and peer support for persons who inject drugs in Haiphong, Vietnam: a case study with implications for interventions.
Des Jarlais D; Duong HT; Pham Minh K; Khuat OH; Nham TT; Arasteh K; Feelemyer J; Heckathorn DD; Peries M; Moles JP; Laureillard D; Nagot N;
AIDS Care; 2016 Oct; 28(10):1312-5. PubMed ID: 27178119
[TBL] [Abstract][Full Text] [Related]
46. Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
Zhang L; Celentano DD; Le Minh N; Latkin CA; Mehta SH; Frangakis C; Ha TV; Mo TT; Sripaipan T; Davis WW; Quan VM; Go VF
Eur J Gastroenterol Hepatol; 2015 May; 27(5):550-6. PubMed ID: 25769097
[TBL] [Abstract][Full Text] [Related]
47. Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
Makarenko I; Mazhnaya A; Marcus R; Bojko MJ; Madden L; Filippovich S; Dvoriak S; Altice FL
Int J Drug Policy; 2017 Jul; 45():56-63. PubMed ID: 28628853
[TBL] [Abstract][Full Text] [Related]
48. Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico.
Abadie R; Welch-Lazoritz M; Gelpi-Acosta C; Reyes JC; Dombrowski K
Harm Reduct J; 2016 Mar; 13():10. PubMed ID: 26956029
[TBL] [Abstract][Full Text] [Related]
49. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
[TBL] [Abstract][Full Text] [Related]
50. Drug scene, drug use and drug-related health consequences and responses in Kulob and Khorog, Tajikistan.
Latypov A; Otiashvili D; Zule W
Int J Drug Policy; 2014 Nov; 25(6):1204-14. PubMed ID: 25449057
[TBL] [Abstract][Full Text] [Related]
51. A mixed methods exploration of injection drug use risk behaviors and place-based norms in Ukraine.
Owczarzak J; Slutsker JS; Mazhnaya A; Tobin K; Kiriazova T
J Subst Use Addict Treat; 2023 Nov; 154():209135. PubMed ID: 37544509
[TBL] [Abstract][Full Text] [Related]
52. HIV and HCV among people who inject drugs in Central Asia.
Walsh N; Maher L
Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S37-40. PubMed ID: 23906997
[TBL] [Abstract][Full Text] [Related]
53. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
[TBL] [Abstract][Full Text] [Related]
54. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.
Rosińska M; Sierosławski J; Wiessing L
BMC Infect Dis; 2015 Feb; 15():83. PubMed ID: 25879904
[TBL] [Abstract][Full Text] [Related]
55. Respondent-driven sampling is more efficient than facility-based strategies at identifying undiagnosed people who inject drugs living with HIV in India.
McFall AM; Solomon SS; Lau B; Latkin C; Srikrishnan AK; Anand S; Vasudevan CK; Kumar MS; Lucas GM; H Mehta S
Drug Alcohol Depend; 2023 Aug; 249():110834. PubMed ID: 37352733
[TBL] [Abstract][Full Text] [Related]
56. HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.
Ray Saraswati L; Sarna A; Sebastian MP; Sharma V; Madan I; Thior I; Pulerwitz J; Tun W
BMC Public Health; 2015 Jul; 15():726. PubMed ID: 26223866
[TBL] [Abstract][Full Text] [Related]
57. Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study.
Tan J; Altice FL; Madden LM; Zelenev A
Lancet HIV; 2020 Feb; 7(2):e121-e128. PubMed ID: 31879250
[TBL] [Abstract][Full Text] [Related]
58. Low HIV testing among persons who inject drugs-National HIV Behavioral Surveillance, 20 U.S. cities, 2012.
Cooley LA; Wejnert C; Spiller MW; Broz D; Paz-Bailey G;
Drug Alcohol Depend; 2016 Aug; 165():270-4. PubMed ID: 27323649
[TBL] [Abstract][Full Text] [Related]
59. HIV prevalence and risk behaviors among people who inject drugs in two serial cross-sectional respondent-driven sampling surveys, Zanzibar 2007 and 2012.
Matiko E; Khatib A; Khalid F; Welty S; Said C; Ali A; Othman A; Haji S; Kibona M; Kim E; Broz D; Dahoma M
AIDS Behav; 2015 Feb; 19 Suppl 1(Suppl 1):S36-45. PubMed ID: 25399032
[TBL] [Abstract][Full Text] [Related]
60. Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa.
Mumtaz GR; Weiss HA; Vickerman P; Larke N; Abu-Raddad LJ
AIDS; 2015 Aug; 29(13):1701-10. PubMed ID: 26372281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
